US EditionLilly becomes first drugmaker to join trillion-dollar club on weight-loss demand boom
Lilly's weight-loss drugs generated nearly $19 billion in nine months, pushing its stock up over 35% this year amid soaring global obesity treatment demand.
- On Friday, Eli Lilly hit $1 trillion in market value, briefly touching the milestone in morning trade before retreating, becoming the first drugmaker to join the club.
- Growing demand for obesity drugs prompted Eli Lilly's shift after tirzepatide's approval helped it pivot from diabetes to obesity with Zepbound and Mounjaro, turning treatments into a lucrative segment.
- In the latest quarter, Lilly reported more than $10.09 billion from its obesity and diabetes portfolio, over half of $17.6 billion total revenue, and its stock rally has exceeded 35% this year.
- Wall Street projects the weight-loss market at $150 billion by 2030, with Lilly and Novo controlling most sales, while Lilly's White House pricing deal and production investments aim to support growth amid margin pressures.
- Investors are now focused on Lilly's oral obesity drug orforglipron, expected early next year, while Citi analysts say the GLP-1 class's success could boost its market entry against Novo Nordisk.
64 Articles
64 Articles
Eli Lilly becomes first healthcare company to hit $1 trillion
Silicon Valley’s giants crowd the list of the world’s most valuable companies, but drugmaker Eli Lilly is hot on their heels. The company topped a market capitalization of $1 trillion on Friday, becoming the first business in the health industry to hit that milestone. Lilly’s achievement comes during a tense week for stock watchers. AI chipmaker Nvidia, which itself became the first $5 trillion company less than a month ago, beat expectations wi…
The world’s largest drug manufacturer, Eli Lilly, has just reached another milestone: it is the first health care company to cross the trillion dollar threshold, as investors are betting heavily on the manufacturer’s weight loss drugs. Lilly’s shares rose to 1.7 percent on Friday, raising its market value to about a trillion dollars, according to data collected by Bloomberg. With this breakthrough, Lilly has consolidated its position as the firs…
Coverage Details
Bias Distribution
- 49% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
